News Roche Holding AG

Equities

ROG

CH0012032048

Pharmaceuticals

Market Closed - Swiss Exchange Other stock markets 16:31:47 11/07/2025 BST			5-day change	1st Jan Change
256.80 ^CHF	-2.36%		-0.31%	+0.51%

07-10	ROCHE HOLDINGS AG : Buy rating from UBS	ZD
07-09	Swiss Market Index Closes Higher; SGS Shares Down	MT

ROCHE HOLDINGS AG : Buy rating from UBS	07-10	ZD
Swiss Market Index Closes Higher; SGS Shares Down	07-09	MT
ROCHE HOLDINGS AG : JP Morgan reaffirms its Sell rating	07-09	ZD
Deutsche Bank Remains Cautious on Pharmaceutical Sector Ahead of Earnings Season	07-08	FW
ROCHE HOLDINGS AG : Deutsche Bank gives a Sell rating	07-08	ZD
Precision Genetic Medicine Platform Could Disrupt Standard of Care in Metastatic Cancer, Other Indications of Unmet Needs	07-07	AQ
European shares fall as banks, mining stocks losses weigh	07-04	RE
Swiss Market Index Closes Flat; Drugmakers Gain on US-Swiss Trade Deal Talks	07-04	MT
ROCHE HOLDINGS AG : Goldman Sachs reaffirms its Sell rating	07-04	ZD
Roche's Lebanese Unit Renews Healthcare Collaboration with Universities	07-03	MT
Berenberg Cuts Zealand Pharma's Price Target Amid Increased Competition	07-01	MT
ROCHE HOLDINGS AG : UBS reaffirms its Buy rating	07-01	ZD
Amgen says gastric cancer drug meets main goal in late-stage trial	06-30	RE
Rakovina Therapeutics Inc. Highlights Strong H1 Progress and Unveils Strategic Priorities for H2 2025	06-30	CI
ROCHE HOLDINGS AG : Receives a Sell rating from JP Morgan	06-30	ZD
Roche Head of Pharma Research and Early Development to Retire	06-30	DJ
Bayer Receives EU Approval for Extended Eylea Treatment Intervals	06-27	DP
Roche Diagnostics, Egypt's UPA Partner to Advance Green Procurement in Healthcare	06-26	MT
Roche Holding AG - Special Call	06-23
Lineage Cell Therapeutics, Inc. Announces 36-Month Visual Acuity Results Featured at Clinical Trials at the Summit 2025	06-23	CI
Roche: positive Phase I/II data in hemophilia A	06-23	CF
Roche's Hemophilia Drug Shows Hemostatic Normalization Potential in Early-stage Study	06-23	MT
Swiss stocks - Factors to watch on June 23	06-23	RE
Roche's Investigational Therapy for Lymphoma Demonstrates 'Significant' Improvement	06-22	MT
Roche's Lymphoma Treatment Shows Promise in Late-Stage Trial	06-20	DJ